Stephen A. Hill

Former Director, President & Chief Executive Officer at Catalyst Biosciences, Inc.

Stephen A. Hill

Stephen A. Hill

Former Director, President & Chief Executive Officer at Catalyst Biosciences, Inc.

Overview

Career Highlights

Faraday Pharmaceuticals, Inc.
Catalyst Biosciences, Inc.
Targacept, Inc.

RelSci Relationships

660

Number of Boards

10

Birthday

1958

Age

62

Relationships

View Relationship Details

RelSci Relationships are individuals Stephen A. Hill likely has professional access to. A relationship does not necessarily indicate a personal connection.

Nassim Usman

President & Chief Executive Officer at Catalyst Biosciences, Inc.

Relationship likelihood: Strong

Mark Roth

Founder at Faraday Pharmaceuticals, Inc.

Relationship likelihood: Strong

Errol B. De Souza

Executive Chairman at nLife Therapeutics SL

Relationship likelihood: Strong

Gus Lawlor

Managing Director at HealthCare Ventures LLC

Relationship likelihood: Strong

Steven Gillis

Managing Director at ARCH Venture Partners

Relationship likelihood: Strong

Barry Selick

Vice Chancellor of Innovation & Partnerships at University of California - San Francisco

Relationship likelihood: Strong

John P. Richard

Co-Founder at Mereo BioPharma Group Plc

Relationship likelihood: Strong

James Caruso

President, Chief Executive Officer & Director at Cellectar BioSciences, Inc.

Relationship likelihood: Strong

Mahesh V. Patel

Chairman of the Board, President & Chief Executive Officer at Lipocine, Inc.

Relationship likelihood: Strong

Paul Berns

Venture Partner at ARCH Venture Partners

Relationship likelihood: Strong

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.

In The News

Targeted News Service

October 2, 2020

Fred Hutchinson Cancer Research Center: Study Reveals Element in Blood is Part of Human - and Hibernating Squirrel - Stress Response

PR Newswire

November 19, 2019

Faraday Pharmaceuticals Announces Positive Top-Line Results from Phase 2 Trial of FDY-5301 for Treatment of Reperfusion Injury Following a STEMI Heart Attack; Treatment well tolerated, with encouraging signs to support pivotal trial

Triad Business Journal (Greensboro, North Carolina)

September 4, 2015

Former Triad biotech CEO lands with Seattle pharma company

PR Newswire

September 3, 2015

Faraday Pharmaceuticals Announces the Appointment of Dr. Stephen A. Hill as Chief Executive Officer

Milwaukee Business Journal

June 16, 2015

Cellectar Biosciences names new CEO :

Paths to Stephen A. Hill

Potential Connections via
Relationship Science

You

Stephen A. Hill

Former Director, President & Chief Executive Officer at Catalyst Biosciences, Inc.

Education

University of Oxford

Oxford is a collegiate university, consisting of the central University and colleges. The central University is composed of academic departments and research centres, administrative departments, libraries and museums. The 38 colleges are self-governing and financially independent institutions, which are related to the central University in a federal system. There are also six permanent private halls, which were founded by different Christian denominations and which still retain their Christian character.

Medical Degree

St. Catherine's College - Oxford

Memberships

Fellow

Current

The Royal College of Surgeons of England

The Royal College of Surgeons of England (abbreviated RCS and sometimes RCSEng), is an independent professional body and registered charity promoting and advancing standards of surgical care for patients, regulating surgery, including dentistry, in England and Wales.

Career History

President & Chief Executive Officer

2008 - 2010

Solvay Pharmaceuticals, Inc.

Solvay Pharmaceuticals, Inc manufactures pharmaceutical products. The company produces therapies for cardi-metabolic, gastroenterological, and neurological disorders. Its brands include Androgel, Klonopin, and ACEON drugs. Solvay Pharmaceuticals was founded by Ernest Solvay in 1863 and is located in Marietta, GA.

President, Chief Executive Officer & Director

1999 - 2008

ArQule, Inc.

ArQule, Inc. is a biopharmaceutical company. It engages in the research and development of therapeutics to treat cancers and rare diseases. The company was founded in 1993 and is headquartered in Burlington, MA.

President & Chief Executive Officer

Prior

Unimed Pharmaceuticals LLC

Unimed Pharmaceuticals, Inc. manufactured pharmaceutical products. It provided multiple indications in the therapeutic areas of cardiology, men's health, HIV and other infectious diseases. The company was founded in 1999 and was headquartered in Marietta, GA.

Boards & Committees

Chief Executive Officer & Director

2015 - Current

Faraday Pharmaceuticals, Inc.

Faraday Pharmaceuticals, Inc. engages in the research and development of elemental reducing agents (ERAs). Its therapeutic agents have potential applications for treatment of critical care illnesses. The company was founded by Mark B. Roth and Christopher Toombs in 2014 and is headquartered in Seattle, WA.

Lead Independent Director

2014 - Current

Lipocine, Inc.

Lipocine, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development for the delivery of drugs using proprietary delivery technology. The firm involves in applying oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. It offers TLANDO, an oral testosterone replacement therapy. The company was founded in 2011 and is headquartered in Salt Lake City, UT.

Director

2007 - Current

Cellectar BioSciences, Inc.

Cellectar BioSciences, Inc. engages in the development of phospholipid drug conjugates (PDCs) for the treatment and imaging of cancer. Its portfolio includes CLR 131, which seeks to treat relapse or refractory multiple myeloma; CLR 125, which intends to treat micro metastatic disease; CLR 124 which could detects tumors and metastases in a broad range of cancers; and CLR 1502, a cancer-targeting near-infrared-fluorophore optical imaging PDC for intraoperative tumor and tumor margin illumination. The company was founded in June 1996 and is headquartered in Florham Park, NJ.

Public Holdings

Restricted data only for RelSci Professional users.

Other Affiliations

Stephen A. Hill is affiliated with Solvay Pharmaceuticals, Inc., ArQule, Inc., Unimed Pharmaceuticals LLC, 21st Century Biodefense, Inc., Targacept, Inc., National Health Service, Faraday Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd., QUE Oncology, Inc., Hoffmann-La Roche Ltd., Catalyst Biosciences, Inc., Roche Holding AG, Faraday Pharmaceuticals, Inc., Lipocine, Inc., Cellectar BioSciences, Inc., Faraday Pharmaceuticals, Inc. (Washington), Catalyst Biosciences, Inc., Targacept, Inc., Catalyst Bioscience, Inc. (Inactive), Audeo Oncology, Inc., Novelos Therapeutics, Inc., ArQule, Inc., F. Hoffmann-La Roche Ltd.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Stephen A. Hill. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Stephen A. Hill's profile does not indicate a business or promotional relationship of any kind between RelSci and Stephen A. Hill.